Redpoint Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$5.63M Sell
17,414
-2,738
-14% -$867K 0.82% 17
2022
Q2
$6.53M Buy
20,152
+55
+0.3% +$16.5K 0.77% 19
2022
Q1
$5.75M Hold
20,097
0.58% 27
2021
Q4
$5.55M Sell
20,097
-395
-2% -$100K 0.44% 51
2021
Q3
$4.74M Sell
20,492
-1,753
-8% -$433K 0.4% 61
2021
Q2
$5.11M Sell
22,245
-875
-4% -$176K 0.42% 54
2021
Q1
$4.32M Buy
23,120
+142
+0.6% +$27.8K 0.37% 66
2020
Q4
$3.88M Buy
22,978
+1,686
+8% +$252K 0.39% 63
2020
Q3
$3.15M Sell
21,292
-29,098
-58% -$4.5M 0.34% 79
2020
Q2
$8.27M Sell
50,390
-13,266
-21% -$2.04M 0.46% 54
2020
Q1
$8.83M Hold
63,656
0.55% 38
2019
Q4
$8.37M Sell
63,656
-4,488
-7% -$520K 0.41% 55
2019
Q3
$7.62M Buy
68,144
+825
+1% +$91.8K 0.4% 55
2019
Q2
$7.46M Buy
67,319
+806
+1% +$94.9K 0.39% 54
2019
Q1
$8.63M Buy
66,513
+73
+0.1% +$8.88K 0.43% 51
2018
Q4
$7.69M Sell
66,440
-864
-1% -$96.5K 0.45% 45
2018
Q3
$7.22M Hold
67,304
0.36% 64
2018
Q2
$5.74M Buy
67,304
+934
+1% +$76.7K 0.31% 77
2018
Q1
$5.13M Buy
66,370
+5,736
+9% +$462K 0.29% 90
2017
Q4
$5.12M Buy
+60,634
New +$5.16M 0.28% 92

Other funds holding LLY

Redpoint Investment Management's LLY Position: Q3 2022 in Review

Redpoint Investment Management reduced its Eli Lilly (LLY) stake by 14% in Q3 2022, selling an estimated $867K and leaving 17,414 shares worth $5.63M. The position accounts for 0.82% of the portfolio, ranked #17.

Redpoint Investment Management first reported a position in LLY in Q4 2017 and has held it in 20 quarters since. The position peaked at $8.83M in Q1 2020. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Redpoint Investment Management held 17,414 shares of Eli Lilly worth $5.63M as of Q3 2022.
  • Redpoint Investment Management sold 2,738 Eli Lilly shares in Q3 2022, an estimated $867K.
  • Eli Lilly made up 0.82% of Redpoint Investment Management's portfolio in Q3 2022, its #17 holding.
  • Redpoint Investment Management first reported a position in Eli Lilly in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's Eli Lilly position peaked at $8.83M in Q1 2020.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.